2nd Annual Biomarker Discovery Europe Conference to Be Held by GTCbio on October 1-2, 2009 in Lisbon, Portugal.
The cost to discover and develop a drug is increasing dramatically both in Europe and the US. Making things more difficult, as the aforementioned costs rise, the number of approved new drug products is on the decline. Drug manufacturers are desperately searching for ways to increase the efficiency of the drug discovery process while decreasing the costs and time it takes for the necessary approvals.